We observed significantly higher levels of proinflammatory cytokines IL-1β, IL-6, and TNF-α in plasma of stroke mice and the BR therapy decreased the levels of these cytokines in plasma (Fig. 5). The gene discussed is IL6; the disease is Stroke.